# "The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"

> **NCT06656442** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Trimetazidine

## Key facts

- **NCT ID:** NCT06656442
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-05-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06656442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06656442, ""The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06656442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
